Last reviewed · How we verify
NCT07323043
Comparison of Cough Response Between Tegilidine and Sufentanil as Pre-induction Agents in General Anesthesia
NA trial testing Tegilidine in General Anesthetic Drug Adverse Reaction in 190 participants. Currently enrolling.
16 May 2026
Quick facts
| Lead sponsor | The First People's Hospital of Lianyungang |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 190 |
| Start date | 15 January 2026 |
| Primary completion | 16 May 2026 |
| Estimated completion | 16 June 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Tegilidine — full drug profile →
- Sufentanil (SUFENTANIL) — full drug profile →
Conditions studied
- General Anesthetic Drug Adverse Reaction — all drugs for General Anesthetic Drug Adverse Reaction →
Sponsor
The First People's Hospital of Lianyungang
Who can join
Adults 18 to 65, any sex, with General Anesthetic Drug Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In patients undergoing general anesthesia with planned tracheal intubation , a prospective, randomized, controlled, double-blind study was conducted to record the occurrence of cough 2 minutes after injection of Sufentanil or tegilidine. The cough was graded based on the frequency and duration: Grade I, no cough; Grade II, a single mild cough; Grade III, multiple coughs with duration \<1 second; Grade IV, continuous coughing with a duration \>15 seconds.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07323043
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for General Anesthetic Drug Adverse Reaction
Currently open trials in the same condition.
- NCT07287683 — Evaluation of Postoperative Pain in Cases Undergoing Cataract Surgery Under Topical Versus General Anesthesia · Phase 1, PHASE2 · active not recruiting
- NCT06707532 — The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA) · NA · recruiting
- NCT06216002 — Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery · NA · recruiting
Other The First People's Hospital of Lianyungang trials
Trials by the same sponsor.
- NCT07481006 — Association Between Intraoperative Mean Arterial Pressure Variability and Postoperative Fatigue in Patients Undergoing L · not yet recruiting
- NCT07279051 — Modified Mini-Open TLIF vs Traditional Open TLIF · NA · not yet recruiting
- NCT07096115 — ED90 of Teglidine for Suppressing LMA Insertion Response in the Elderly · NA · not yet recruiting
- NCT07081477 — Ciprofol's Influence on LVOT VTI in Elderly Painless Colonoscopy Patients · NA · not yet recruiting
- NCT06987630 — Integrated Pulmonary Index Monitoring on the Incidence of Hypoxemia in Elderly Patients With Painless Colonoscopy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07323043 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First People's Hospital of Lianyungang
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07323043.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing